안저 카메라 시장 : 규모, 점유율, 성장률, 산업 분석, 유형별, 용도별, 지역별 고찰, 예측(2026-2034년)

Growth Factors of fundus camera Market

The global fundus camera market was valued at USD 654.08 million in 2025 and is projected to grow to USD 691.51 million in 2026, reaching USD 1,116.81 million by 2034, exhibiting a CAGR of 6.18% during the forecast period. North America dominated the market with a 36.40% share in 2025, driven by strong healthcare infrastructure and early adoption of advanced ophthalmic imaging technologies.

Market Overview

A fundus camera is a specialized ophthalmic device used to capture detailed images of the retina, optic disc, and macula. It plays a crucial role in diagnosing and monitoring eye conditions such as diabetic retinopathy, glaucoma, and age-related macular degeneration (AMD).

The market is witnessing steady growth due to the rising global burden of eye diseases and increasing awareness regarding early diagnosis. Fundus imaging has become an essential diagnostic tool in both hospitals and specialized eye clinics.

Market Drivers

One of the primary growth drivers is the rising prevalence of ophthalmic disorders coupled with a rapidly aging population. Increasing cases of diabetes have significantly contributed to higher incidences of diabetic retinopathy globally.

Additionally, studies indicate that a large percentage of individuals aged 60 and above experience some form of visual impairment, increasing the demand for diagnostic tools such as fundus cameras. The growing need for early detection and monitoring is accelerating market adoption.

Market Restraints

Despite strong demand, the market faces challenges due to the high cost of fundus cameras. Advanced systems equipped with AI and high-resolution imaging can range between USD 10,000 and USD 50,000, making them less accessible for smaller clinics and healthcare providers in developing regions.

Furthermore, the requirement for skilled professionals to operate these devices limits adoption, especially in underserved areas.

Market Opportunities

The increasing use of fundus cameras in telemedicine presents significant growth opportunities. With advancements in digital healthcare, remote diagnosis has become more feasible, particularly in rural and remote regions.

Portable and AI-enabled fundus cameras allow healthcare providers to capture and share retinal images for expert analysis, improving accessibility and early diagnosis rates.

Market Trends

A key trend shaping the market is the integration of artificial intelligence (AI) in fundus imaging systems. AI-powered devices enhance diagnostic accuracy and reduce the workload on ophthalmologists by enabling automated detection of eye diseases.

These innovations are transforming ophthalmology by enabling faster and more efficient screening, particularly for large populations.

Segmentation Analysis

By Product Type

Non-mydriatic cameras dominate the market due to their ability to capture retinal images without pupil dilation, offering greater patient comfort and faster diagnosis.

By Portability

Handheld fundus cameras are gaining traction due to their portability and suitability for remote and telemedicine applications, while tabletop devices remain widely used for high-quality imaging.

By Indication

The diabetic retinopathy segment holds a major share due to the increasing number of diabetic patients worldwide, requiring regular retinal screening.

By End-user

Hospitals dominate the market due to high patient inflow, while ophthalmic clinics are expected to grow at the highest CAGR due to increasing specialization.

Regional Insights

North America leads the market with a valuation of USD 237.09 million in 2025, expected to reach USD 249.65 million in 2026, driven by advanced healthcare systems.

Europe accounted for USD 207.06 million in 2025 and continues to grow due to strong medical infrastructure and skilled professionals.

Asia Pacific is expected to witness the highest growth due to rising awareness, increasing diabetes prevalence, and expanding screening programs, reaching USD 160.87 million in 2026.

Latin America and Middle East & Africa show steady growth due to improving healthcare infrastructure and increasing awareness of eye health.

Competitive Landscape

The market is highly competitive with key players such as Carl Zeiss Meditech AG, Topcon Corporation, and NIDEK CO., LTD. dominating the global landscape. These companies focus on product innovation, partnerships, and AI integration to strengthen their market position.

Conclusion

In conclusion, the fundus camera market is poised for steady growth from USD 654.08 million in 2025 to USD 1,116.81 million by 2034, driven by the rising burden of eye diseases, technological advancements, and increasing adoption of telemedicine. While high costs and lack of skilled professionals remain challenges, innovations such as AI-powered and portable devices are expected to bridge these gaps. As healthcare systems worldwide prioritize early diagnosis and preventive care, the demand for fundus imaging solutions will continue to expand significantly in the coming years.

Segmentation By Product Type

• Non-Mydriatic Cameras
• Mydriatic Cameras
• Others

By Portability

• Tabletop
• Handheld

By Indication

• Diabetic Retinopathy
• Glaucoma
• Age-Related Macular Degeneration (AMD)
• Others

By End-user

• Hospitals
• Ophthalmic Clinics
• Others

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Prevalence of Key Conditions, By Key Countries/Region, 2025
• 4.2. Overview of Regulatory Scenario
• 4.3. Key Industry Developments - (Mergers, Acquisition & Partnerships, etc.)
• 4.4. New Product Launch/Approvals, By Key Players
• 4.5. Impact of COVID-19 on the Market

5. Global Fundus Camera Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Product Type
  • 5.1.1. Non-Mydriatic Cameras
  • 5.1.2. Mydriatic Cameras
  • 5.1.3. Others
• 5.2. Market Analysis, Insights and Forecast - By Portability
  • 5.2.1. Tabletop
  • 5.2.2. Handheld
• 5.3. Market Analysis, Insights and Forecast - By Indication
  • 5.3.1. Diabetic Retinopathy
  • 5.3.2. Glaucoma
  • 5.3.3. Age-Related Macular Degeneration (AMD)
  • 5.3.4. Others
• 5.4. Market Analysis, Insights and Forecast - By End-user
  • 5.4.1. Hospitals
  • 5.4.2. Ophthalmic Clinics
  • 5.4.3. Others
• 5.5. Market Analysis, Insights and Forecast - By Region
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa

6. North America Fundus Camera Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Product Type
  • 6.1.1. Non-Mydriatic Cameras
  • 6.1.2. Mydriatic Cameras
  • 6.1.3. Others
• 6.2. Market Analysis, Insights and Forecast - By Portability
  • 6.2.1. Tabletop
  • 6.2.2. Handheld
• 6.3. Market Analysis, Insights and Forecast - By Indication
  • 6.3.1. Diabetic Retinopathy
  • 6.3.2. Glaucoma
  • 6.3.3. Age-Related Macular Degeneration (AMD)
  • 6.3.4. Others
• 6.4. Market Analysis, Insights and Forecast - By End-user
  • 6.4.1. Hospitals
  • 6.4.2. Ophthalmic Clinics
  • 6.4.3. Others
• 6.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 6.5.1. U.S.
  • 6.5.2. Canada

7. Europe Fundus Camera Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Product Type
  • 7.1.1. Non-Mydriatic Cameras
  • 7.1.2. Mydriatic Cameras
  • 7.1.3. Others
• 7.2. Market Analysis, Insights and Forecast - By Portability
  • 7.2.1. Tabletop
  • 7.2.2. Handheld
• 7.3. Market Analysis, Insights and Forecast - By Indication
  • 7.3.1. Diabetic Retinopathy
  • 7.3.2. Glaucoma
  • 7.3.3. Age-Related Macular Degeneration (AMD)
  • 7.3.4. Others
• 7.4. Market Analysis, Insights and Forecast - By End-user
  • 7.4.1. Hospitals
  • 7.4.2. Ophthalmic Clinics
  • 7.4.3. Others
• 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 7.5.1. U.K.
  • 7.5.2. Germany
  • 7.5.3. France
  • 7.5.4. Spain
  • 7.5.5. Italy
  • 7.5.6. Scandinavia
  • 7.5.7. Rest of Europe

8. Asia pacific Fundus Camera Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Product Type
  • 8.1.1. Non-Mydriatic Cameras
  • 8.1.2. Mydriatic Cameras
  • 8.1.3. Others
• 8.2. Market Analysis, Insights and Forecast - By Portability
  • 8.2.1. Tabletop
  • 8.2.2. Handheld
• 8.3. Market Analysis, Insights and Forecast - By Indication
  • 8.3.1. Diabetic Retinopathy
  • 8.3.2. Glaucoma
  • 8.3.3. Age-Related Macular Degeneration (AMD)
  • 8.3.4. Others
• 8.4. Market Analysis, Insights and Forecast - By End-user
  • 8.4.1. Hospitals
  • 8.4.2. Ophthalmic Clinics
  • 8.4.3. Others
• 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 8.5.1. Japan
  • 8.5.2. China
  • 8.5.3. India
  • 8.5.4. Australia
  • 8.5.5. Southeast Asia
  • 8.5.6. Rest of Asia Pacific

9. Latin America Fundus Camera Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Product Type
  • 9.1.1. Non-Mydriatic Cameras
  • 9.1.2. Mydriatic Cameras
  • 9.1.3. Others
• 9.2. Market Analysis, Insights and Forecast - By Portability
  • 9.2.1. Tabletop
  • 9.2.2. Handheld
• 9.3. Market Analysis, Insights and Forecast - By Indication
  • 9.3.1. Diabetic Retinopathy
  • 9.3.2. Glaucoma
  • 9.3.3. Age-Related Macular Degeneration (AMD)
  • 9.3.4. Others
• 9.4. Market Analysis, Insights and Forecast - By End-user
  • 9.4.1. Hospitals
  • 9.4.2. Ophthalmic Clinics
  • 9.4.3. Others
• 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Rest of Latin America

10. Middle East & Africa Fundus Camera Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Product Type
  • 10.1.1. Non-Mydriatic Cameras
  • 10.1.2. Mydriatic Cameras
  • 10.1.3. Others
• 10.2. Market Analysis, Insights and Forecast - By Portability
  • 10.2.1. Tabletop
  • 10.2.2. Handheld
• 10.3. Market Analysis, Insights and Forecast - By Indication
  • 10.3.1. Diabetic Retinopathy
  • 10.3.2. Glaucoma
  • 10.3.3. Age-Related Macular Degeneration (AMD)
  • 10.3.4. Others
• 10.4. Market Analysis, Insights and Forecast - By End-user
  • 10.4.1. Hospitals
  • 10.4.2. Ophthalmic Clinics
  • 10.4.3. Others
• 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 10.5.1. GCC
  • 10.5.2. South Africa
  • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. Carl Zeiss Meditech AG
    • 11.2.1.1. Overview
    • 11.2.1.2. Products
    • 11.2.1.3. SWOT Analysis
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. Financials (Based on Availability)
  • 11.2.2. Kowa Company, Ltd.
    • 11.2.2.1. Overview
    • 11.2.2.2. Products
    • 11.2.2.3. SWOT Analysis
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. Financials (Based on Availability)
  • 11.2.3. Optomed
    • 11.2.3.1. Overview
    • 11.2.3.2. Products
    • 11.2.3.3. SWOT Analysis
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. Financials (Based on Availability)
  • 11.2.4. Topcon Corporation
    • 11.2.4.1. Overview
    • 11.2.4.2. Products
    • 11.2.4.3. SWOT Analysis
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. Financials (Based on Availability)
  • 11.2.5. NIDEK CO., LTD.
    • 11.2.5.1. Overview
    • 11.2.5.2. Products
    • 11.2.5.3. SWOT Analysis
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. Financials (Based on Availability)
  • 11.2.6. Haag-Streit Group
    • 11.2.6.1. Overview
    • 11.2.6.2. Products
    • 11.2.6.3. SWOT Analysis
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. Financials (Based on Availability)
  • 11.2.7. CANON MEDICAL SYSTEMS CORPORATION
    • 11.2.7.1. Overview
    • 11.2.7.2. Products
    • 11.2.7.3. SWOT Analysis
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. Financials (Based on Availability)
  • 11.2.8. Mediworks
    • 11.2.8.1. Overview
    • 11.2.8.2. Products
    • 11.2.8.3. SWOT Analysis
    • 11.2.8.4. Recent Developments
    • 11.2.8.5. Strategies
    • 11.2.8.6. Financials (Based on Availability)
  • 11.2.9. Visionix
    • 11.2.9.1. Overview
    • 11.2.9.2. Products
    • 11.2.9.3. SWOT Analysis
    • 11.2.9.4. Recent Developments
    • 11.2.9.5. Strategies
    • 11.2.9.6. Financials (Based on Availability)